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Abstract 
Purpose 
To validate and compare the values of “MIC” and “trifecta” as predictors of operated kidney 
functional preservation in a multi-institutional cohort of patients undergoing minimally invasive 
PN. 
Methods 
We retrospectively reviewed records of consecutive cases of minimally invasive PN performed for 
cT1 renal masses in 4 centers from 2009 to 2013. Inclusion criteria consisted of availability of a 
renal scan obtained within 2 weeks prior to surgery and follow-up renal scan 3–6 months after the 
surgery. The primary endpoint of the study was to compare the degree of ipsilateral renal function 
preservation assessed by MAG3 renal scan in relation to achievement of MIC and trifecta. 
Results 
Total of 351 patients met our inclusion criteria. The rates of trifecta achievement for cT1a and cT1b 
tumors were 78.9 and 60.6 %, respectively. The rate of MIC achievement for cT1a tumors and cT1b 
tumors was 60.3 and 31.7 %, respectively. On multivariable linear regression model, only the 
degree of tumor complexity assessed by R.E.N.A.L nephrometry score [coefficient B −1.8 (−2.7, 
−0.9); p < 0.0001] and the achievement of trifecta [coefficient B 6.1 (2.4,9.8); p = 0.014] or MIC 
(coefficient B 7.2 (3.8,0.6); p < 0.0001) were significant clinical factors predicting ipsilateral split 
function preservation. 
Conclusions 
Achievement of both MIC and “trifecta” is associated with higher proportion of split renal function 
preservation for cT1 tumors after minimally invasive PN. Thus, these outcome measures can be 
regarded not only as markers of surgical quality, but also as reliable surrogates for predicting 
functional outcome in the operated kidney. 
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Introduction 
Preservation of renal function is the discriminating factor differentiating partial nephrectomy (PN) 
from radical nephrectomy. The evolution of minimally invasive PN and in particular introduction of 
robotic technology have led to widespread uptake and utilization of PN [1]. In order to simplify and 
standardize the reporting and comparison of the outcomes of minimally invasive PN, various groups 
have proposed composite outcome measure tools, such as “MIC” (margin, ischemia and 
complications) and “trifecta” [2–5]. 
With regard to negative surgical margin and no manifestations of complications (albeit with some 
differences), there is consensus among the proposed measures, but with regard to best surrogates for 
renal function preservation, opinions vary [6]. 
Assessment of functional outcome after PN represents a complex issue with the involvement of 
several factors that might not be easily appraised in the perioperative phase [7, 8]. Purpose of the 
above-mentioned composite outcome measures is to streamline and simplify reporting PN 
outcomes. Although proven to be important, incorporation of factors such as amount of renal 
parenchyma resected, renal functional volume assessment or functional outcome assessment by 
renal scan into such composite outcome measures defies their primary purpose and limits their 
widespread adoption by other scholars. 
From the proposed composite outcome tools [2–5], MIC (no major perioperative complications, 
negative surgical margins and warm ischemia time of <20 min) and our previously described 
trifecta of outcomes (no perioperative complications, negative surgical margins and warm ischemia 
time of ≤25 min) can be assessed retrospectively based on the available documented objective data, 
where the concept of trifecta proposed by Hung (no urological complications, negative surgical 
margins and renal function loss <10 %) also relies on the subjective assessment of the amount of 
renal parenchyma resected intraoperatively. The aim of the present study was to compare and 
validate two of the proposed composite assessment tools relying on objective perioperative data, 
namely MIC and trifecta, as predictors of operated kidney functional preservation in a multi-
institutional cohort of patients undergoing minimally invasive PN. 
Method 
Patient population 
Multi-intuitional data from two North American and two European centers were pooled for the 
purpose of this study. Institutional review board approval and data sharing agreement were obtained 
at each institute. Patients with a single clinical T1 (cT1) renal neoplasm undergoing (minimally 
invasive) laparoscopic or robotic PN with available operated kidney split function assessment 
before and after the surgery were selected for the study. Patients with a solitary kidney were 
excluded from the analysis. 
Surgical technique 
For laparoscopic and robotic PN, both transperitoneal and retroperitoneal approaches were utilized, 
and the details of each surgical approach have been previously reported [9–11]. Most procedures 
were performed with warm renal ischemia, but zero ischemia techniques were employed selectively 
[8, 12]. After tumor resection, renorrhaphy is performed as previously described [9]. 
Preoperative planning 
Tumor dimensions and R.E.N.A.L nephrometry score were assessed on preoperative cross-sectional 
imaging [computed tomography (CT) or magnetic resonance imaging (MRI)]. Renal scan was 
obtained 1–2 weeks prior to surgery. Split function for the operated kidney was assessed using 
MAG3 renal scan preoperatively and 3–6 months postoperatively. Our protocol and rationale for 
obtaining MAG3 renal scan have been previously published [7, 8]. 
Data analysis 
For the purpose of this analysis, demographics data (patient age, BMI, sex, race, Charlson 
comorbidity index (CCI) [13], renal function, chronic kidney disease stage, tumor features 
(maximum tumor size, R.E.N.A.L nephrometry score) [14], modality of surgery (LPN or RPN), 
perioperative outcomes (operative time, ischemia type [warm vs. zero ischemia] and duration of 
warm ischemia time (WIT), estimated blood loss (EBL), intraoperative and postoperative 
complications), histopathology assessment (malignancy, positive surgical margin) and rate of 
trifecta and MIC achievements (as well as the rate of accomplishment for all the subcomponents 
including proportion of cases with WIT>25 min, WIT ≥20 min, positive surgical margin and any 
complications) were collected and assessed. 
Split function of the kidney undergoing PN was documented before and after the procedure. 
Operated (ipsilateral) split function preservation was defined as the percentage of the postoperative-
to-preoperative split function ratio. Details of all the variables were computed for the cT1a (≤4 cm) 
and cT1b (>4 and ≤7 cm) cohorts. The proportion of operated split function preservation was 
compared between the cases with and without trifecta achievement for each cT1 stage. 
Trifecta of outcomes for minimally invasive PN was assessed based on our previously defined 
criteria of no perioperative complications, negative surgical margins and warm ischemia time of 
≤25 min [5]. MIC achievement was defined as no major perioperative complications, negative 
surgical margins and warm ischemia time of <20 min. Postoperative complications were graded 
using Clavien classification [15]. Renal function was reported by assessment of GFR using MDRD 
formula [16]. Chronic kidney disease (CKD) staging was assessed based on NICE guidelines [17]. 
Characteristics of the cohort are presented using descriptive statistics. Continuous variables are 
presented as mean with standard deviation (age, BMI) or median with interquartile range (IQR) 
[CCI, GFR, tumor size, R.E.N.A.L score, split renal function, split renal function preservation, 
operative time, EBL, WIT) and categorical variables are expressed as frequency (percentages). For 
comparison of categorical variables, Chi-square test was utilized. For comparison of median split 
renal function preservation between trifecta and no trifecta subgroups, Mann–Whitney U test was 
employed. Multivariable linear regression model assessing modality of surgery, CCI, R.E.N.A.L 
score, trifecta/MIC achievement (not simultaneously) and preoperative GFR/ipsilateral split renal 
function (not simultaneously) was created to identify factors predicting ipsilateral split renal 
function preservation postoperatively. Significance was set at p value <0.05. Analyses were 
performed using SPSS version 21 software (IBM SPSS Statistics; IBM Corp, Armonk, NY, USA). 
Results 
During the study period 2009–2013, a total of 351 cases met our inclusion criteria and were 
included in the analysis (Fig. 1). Two hundred and forty-seven cases (70.4 %) were assessed as 
cT1a disease. The cohort’s characteristics are outlined in Table 1. The median preoperative GFR for 
the cT1a cohort was 85.4 (69.7–100) mL/min/1.73 m2 with 12.5 % of the cohort having CKD stage 
III or higher. For cT1b cohort, the median baseline GFR was 89 (66.5–100.4) mL/min/1.73 m2 with 
20.2 % of the population having CKD stage III or higher. The median tumor sizes were 2.8 and 
5 cm with median R.E.N.A.L nephrometry scores of 6 and 8 for cT1a and cT1b cohorts, 
respectively. More than 60 % of the PN for each cohort was performed robotically, 60.7 and 63.5 % 
for cT1 and cT1b groups, respectively. 
 
Fig. 1 
Flowchart demonstrating the cohort selection 
Table 1 
Main demographics 
Variables Overall cT1a cT1b p values 
  (n = 351) (n = 247) (n = 104)   
Patient-related 
Age, mean ± SD (years) 59.4 ± 12.1 58.9 ± 12.7 60.5 ± 10.6 0.27 
Male, N (%) 233 (66.4) 166 (67.2) 67 (64.4) 0.61 
BMI, mean ± SD (kg/m
2
) 29 ± 6.1 29.1 ± 6.2 28.8 ± 6.1 0.72 
CCI, median (IQR) 2 (0–3) 2 (0–3) 1 (0–3) 0.82 
Pre-op eGFR, median (IQR) (mL/min/1.73 
m2) 
86.2 (69.4–
100) 
85.4 (69.7–
100) 
89 (66.5–
100.4) 
0.99 
Proportion of patients with CKD stage 3–5 
(%) 
52 (14.8) 31 (12.5) 21 (20.2) 0.14 
Tumor-related 
Tumor size, median (IQR) (cm) 3.2 (2.4–4.3) 2.8 (2.1–3.3) 5 (4.4–5.6) <0.0001 
R.E.N.A.L score, median (IQR) (cc) 7 (5–8) 6 (5–8) 8 (7–10) <0.0001 
Preoperative operated kidney 50 (47–52) 50 (47–52) 49.7 (45.1–53) 0.58 
Split renal function, median (IQR) (%)         
Surgery-related 
RPN, N (%) 216 (61.5) 150 (60.7) 66 (63.5) 0.63 
OR Time, median (IQR) (min) 147 (120–180) 137 (120–174) 162 (128–220) <0.0001 
EBL, median (IQR)(cc) 150 (100–250) 100 (75–200) 200 (100–300) <0.0001 
WIT, median (IQR) (min) 20 (16–25) 19 (15–24) 24 (20–27) <0.0001 
Zero WIT, N (%) 51 (14.5) 39 (15.8) 12 (11.5) 0.30 
RCC, N (%) 285 (81.2) 198 (80.2) 87 (83.7) 0.44 
BMI body mass index, CCI Charlson comorbidity index, EBL estimated blood loss, eGFR estimated 
glomerular function rate, LPN laparoscopic partial nephrectomy, OR operating room, RPN robotic 
partial nephrectomy, WIT warm ischemia time 
Functional, trifecta and MIC outcomes are summarized in Table 2. The rate of trifecta of outcomes 
achievement for cT1a tumors (78.9 %) was higher than the rate observed for cT1b tumors (60.6 %) 
(p < 0.0001). This also was observed when assessing the rates of any complications (cT1a 2.4 vs. 
cT1b 9.6 %; p = 0.009) and proportions of WIT >25 min (cT1a 15.8 vs. cT1b 35.6 %; p < 0.0001). 
We did not discern a statistically significant difference between the positive surgical margin rates 
between cT1a (1 %) and cT1b (4 %) groups (p = 0.18). 
Table 2 
Functional and composite outcomes 
Variables Overall cT1a cT1b p value 
Post-op GFR, median (IQR) (mL/min/1.73 m2) 
83.8 (64.7–
97.8) 
86.7 (67.4–
86.7) 
72 (59.3–90) 0.002 
Postoperative operated kidney split renal 
function, median (IQR) (%) 
43 (37–48) 43 (38–48) 40 (33–47) 0.002 
Ipsilateral split function preservation, median 
(IQR) (%) 
86.3 (77.1–
94.6) 
87.8 (78.9–
96) 
82.6 (70.3–
92.8) 
<0.0001 
Ipsilateral split function preservation 
89.6 (78.7–
96) 
90 (80–96.1) 
87.2 (77.4–
94.5) 
0.16 
In cases with trifecta, median (IQR) (%) 
Ipsilateral split function preservation 
81.1 (71.2–
87.5) 
84.4 (76.9–
90.6) 
76.6 (64.6–
82.8) 
0.001 
In cases without trifecta, median (IQR) (%) 
Ipsilateral split function preservation 
91.7 (81.8–
96.3) 
91.8 (81.8–
98) 
90.7 (80.5–
94.8) 
0.26 
In cases with MIC, median (IQR) (%) 
Ipsilateral split function preservation 
81.6 (70.6–
90.5) 
82.4 (74.2–
91.4) 
79.2 (66.7–
87.3) 
0.03 
In cases without MIC, median (IQR) (%) 
Trifecta N (%) 258 (73.5) 195 (78.9) 63 (60.6) <0.0001 
WIT >25 min N (%) 76 (21.7) 39 (15.8) 37 (35.6) <0.0001 
Any complication N (%) 16 (4.6) 6 (2.4) 10 (9.6) 0.003 
PSM N (%) 11 (3.1) 10 (4) 1 (1) 0.18 
MIC N (%) 182 (51.9) 149 (60.3) 33 (31.7) <0.0001 
WIT ≥20 min N (%) 161 (45.9) 91 (36.8) 70 (67.3) <0.0001 
Major complication N (%) 4 (1.1) 2 (0.8) 2 (1.9) 0.58 
Follow-up time, median (IQR) (months) 11 (6–17.5) 
8.6 (5.7–
16.3) 
12 (6–18) 0.09 
GFR estimated glomerular function rate, PSM positive surgical margin, WIT warm ischemia time 
The rate of MIC achievement for cT1a tumors and cT1b tumors was 60.3 and 31.7 %, respectively. 
In total, 170 (50.4 %) of the cohort achieved the criteria for both classifications where 88 (25.1 %) 
did not meet any of the two measures. 
The median values of operated kidney (ipsilateral) split function preservation for cT1a and cT1b 
tumors were 87.8 % (78.9–96) and 82.6 % (70.3–92.8), respectively. The proportion of ipsilateral 
split function preservation for cT1a tumors with trifecta achievement was significantly higher than 
the cases without the trifecta achievement (90 vs. 84.4 %; p = 0.014). Similar phenomenon was 
observed in cT1b cohort with higher observed proportion of ipsilateral split function preservation 
for cases with trifecta achievement (87.2 vs. 76.6 %; p < 0.0001). 
Similarly, the proportion of ipsilateral split function preservation for cT1a and cT1b tumors with 
MIC achievement was significantly higher than the cases without the MIC achievement (91.8 vs. 
82.4 %; p < 0.0001) and (90.7 vs. 79.2 %; p = 0.002), respectively. 
On multivariable analysis (Table 3), only the degree of tumor complexity assessed by R.E.N.A.L 
nephrometry score (coefficient B −1.8 (−2.7, −0.9); p < 0.0001)) and the achievement of trifecta 
(coefficient B 6.1 (2.4, 9.8); p = 0.014) or MIC (coefficient B 7.2 (3.8, 10.6); p < 0.0001) resulted to 
be significant clinical factors predicting ipsilateral split function preservation. Addition of center to 
multivariable analysis did not change the performance of the other variables, but center itself (both 
as linear and categorical variables) was also a predictor of ipsilateral split function preservation 
(data not shown). 
Table 3 
Multivariable analysis of factors predicting ipsilateral split function preservation 
Variable Coefficient B (95 % CI) p 
RPN versus LPN −2.7 (−6.4, 0.9) 0.13 
CCI −0.5 (−1.5, 0.4) 0.27 
Pre-op GFR* (mL/min/1.73 m
2
) 0.05 (−0.02, 0.1) 0.16 
Trifecta** 6.1 (2.4, 9.8) 0.001 
MIC** 7.2 (3.8, 10.6) <0.0001 
RENAL score −1.8 (−2.7, −0.9) <0.0001 
Pre-op split unction* (%) −0.07 (−0.3, 0.2) 0.63 
CCI Charlson comorbidity index, eGFR estimated glomerular function rate, LPN laparoscopic 
partial nephrectomy, RPN robotic partial nephrectomy 
* And ** values were tested in the model independently 
Discussion 
All proposed classifications for assessing multiple outcomes after PN use surgical margin as one of 
the indictors of quality of surgery and as a surrogate for oncological outcomes [18]. Occurrence of 
perioperative complications is another component of the existing proposed composite outcomes 
although the definition of what should be included is variable among the existing classifications [6]. 
When it comes to preservation of renal function, there are considerable variations between the 
exiting proposed composite outcome tools. These variations stem from complex nature of factors 
influencing functional outcomes after PN. Based on the available evidence, we know that quantity 
of renal parenchyma resected, extended WIT and quality and amount of renal parenchyma 
preserved all influence the functional outcomes after PN [7, 19]. Stating this, currently we lack the 
perfect tool for predicting functional outcomes after PN. CT volume assessment [20], tumor contact 
surface area [21] and renal scan have all been shown to be useful in measuring renal functional 
outcomes, but require labor-intensive renal volume measurement, advance imaging technology or 
additional imaging. Furthermore, the information provided is often not available until after PN. In 
our study, achievement of trifecta/MIC was associated with significantly higher values of operated 
kidney split function than in cases where trifecta/MIC was not obtained. Achievement of trifecta 
was associated with 6.1 % increase in operated kidney split function preservation compared to 10 % 
increase observed with MIC achievement. The rate of trifecta achievement was lower in T1b tumors 
compared to T1a tumors; however, achievement of trifecta was associated with higher degree of 
ipsilateral renal function preservation for T1b tumors (87.2 vs. 76.6) as well as T1a cases (90 vs. 
84.4) on univariable analysis. Similar results were observed with MIC criteria. These findings 
confirm that trifecta and MIC can be regarded as surrogates for quality of surgery and strong 
predictors of functional outcome after PN. However, the more strict WIT criteria (<20 min) 
necessary for MIC achievement had a large impact on the rate of MIC achievement compared to 
trifecta. For example, for cT1a tumors the use of MIC criteria instead of trifecta led to a decrease in 
the number of cases achieving the composite outcome from 195 (78.9 %) to 149 (60.3 %) with 
modest median split function preservation improvement from 90 to 91.8 %. The improvement for 
cT1b tumors was slightly more pronounced, 87.2–90.7 %, but the rate of composite outcome 
achievement decline was also more pronounced, 60.6–31.7 %. This comparison suggests that 
trifecta offers more inclusive and achievable criteria without comprising the functional assessment 
component. 
In our study, tumor complexity also influenced the degree of split renal function preservation, 
which is in line with our understanding of factors influencing renal function after PN. The tumor 
size and degree of complexity directly influence the amount of renal parenchyma resected and 
similarly the nature of renorrhaphy during the reconstruction phase of the procedure [20]. Although 
R.E.N.A.L score has been shown to be a predictor of trifecta achievement [4], given the weak 
correlation observed in our study and their clinical importance, we entered the two variables in our 
multivariable model simultaneously. 
Conditions such as diabetes and hypertension could potentially impact the functional outcomes after 
PN, and we did not specifically control for such factors in our analysis, and this is a potential 
limitation; however, we did adjust for CCI as a surrogate for medical comorbidities. Inclusion of 
preoperative GFR also potentially acts as a surrogate for factors affecting functional outcomes after 
PN as it keeps their direct effects on preexisting renal function into consideration. 
Other factors such as resected healthy renal tissue during PN, with known definitive impact on 
functional outcomes, were not included in the multivariable analysis. Tumor size (cT1 only tumors 
in this analysis) and R.E.N.A.L score control for this element to some extent. Furthermore, one of 
the key objectives of our study was to replace more complex assessment tools such as the amount of 
parenchyma resected with the more simplified perioperative outcome measures such as trifecta, and 
hence, the resected healthy renal tissue was omitted from our multivariable analysis. 
The concept of trifecta after PN is generally applied to cT1 and more specifically to cT1a tumors, 
and hence, we provided the data for cT1a and cT1b tumors separately; however, on multivariable 
analysis assessing the utility of trifecta on functional outcomes, all cT1 tumors were included [6]. 
Further limitations beside the retrospective nature of data include lack of central pathology and 
radiology review that can be a source of data heterogeneity. Similarly, inclusion of laparoscopic and 
robotic cases and presence of trans- and retroperitoneal cases can be another source of data 
heterogeneity; however, we are not comparing the outcomes between these approaches and instead 
assessing the functional outcomes of cases with trifecta achievement regardless of how the 
procedure was performed, and this potentially enriches our cohort. 
It could be contended that a selection bias may exist, based on availability of a renal scan obtained 
within 2 weeks prior to surgery and follow-up renal scan 3–6 months after the surgery and the 
current cohort might not represent our true consecutive experience and rather only include cases 
where renal scan was considered due to existence of potential confounders. In practice, obtaining 
renal scan has become a part of standard protocol for preoperative assessment and follow-up after 
PN in the contributing centers, but after applying the inclusion criteria, the cohort is unlikely to 
present the entire consecutive experience of each contributing center. But as we are comparing 
trifecta achievement to cases where trifecta was not achieved, selection bias is unlikely to influence 
the key findings of our study; however, the overall rate of trifecta achievement might be different. 
Similar discussion applies to learning curve and surgical caseload, known to strongly correlate with 
PN outcomes. Lack of adjustment for these factors is a potential drawback of our analysis, but apart 
from potential impact on the overall rate of MIC or trifecta, this is unlikely to affect the conclusions 
of our study. Furthermore, inclusion of the center as a variable in the multivariable analysis did not 
influence the performance of other variables in the model; however, center itself was also a 
predictor of functional outcomes after PN likely as a factor controlling for operating skills, 
experience and overall patient care. 
In this study, the rates of positive surgical margin and complications are lower than reported in the 
published literature [5]. As experienced high-volume minimally invasive surgeons performed the 
procedures in this cohort, current findings might not be applicable to other settings. 
Conclusions 
Achievement of both MIC and “trifecta” is associated with higher proportion of split renal function 
preservation for both cT1a and cT1b tumors after minimally invasive PN. Thus, these outcome 
measures can be regarded not only as markers of surgical quality, but also as reliable surrogates for 
predicting functional outcome in the operated kidney. “Trifecta,” defined as no perioperative 
complications, negative surgical margins and warm ischemia time of ≤25 min, offers more inclusive 
criteria compared to MIC without significantly compromising the functional assessment. 
Author contributions 
The authors listed below have made substantial contributions to the intellectual content of the paper 
as described below: Conception and design was done by Jihad Kaouk, Francesco Porpiglia, James 
Porter and Sisto Perdona. Acquisition of data was made by Homayoun Zargar, Giuseppe Quarto, 
Riccardo Bertolo and Riccardo Autorino. Homayoun Zargar and Riccardo Autorino analyzed and 
interpreted the data. Homayoun Zargar, Jihad Kaouk, Riccardo Autorino and James Porter drafted 
the manuscript. Jihad Kaouk and Francesco Porpiglia critically revised the manuscript for important 
intellectual content. Statistical analysis was done by Homayoun Zargar. Jihad Kaouk supervised the 
study. 
Compliance with ethical standard 
Conflict of interest 
Jihad Kaouk was Consultant for Endocare. The remaining authors have nothing to declare in 
relation to this work 
Ethical standard 
Ethical standards have been observed during conduction and reporting of this work. Institutional 
review board has approved the protocol for this study. 
References 
1. 1. 
Patel HD et al (2013) Trends in renal surgery: robotic technology is associated with 
increased use of partial nephrectomy. J Urol 189:1229–1235. 
doi:10.1016/j.juro.2012.10.024 CrossRefPubMedGoogle Scholar 
2. 2. 
Hung AJ, Cai J, Simmons MN, Gill IS (2013) “Trifecta” in partial nephrectomy. J Urol 
189:36–42. doi:10.1016/j.juro.2012.09.042 CrossRefPubMedGoogle Scholar 
3. 3. 
Buffi N et al (2012) Margin, ischemia, and complications (MIC) score in partial 
nephrectomy: a new system for evaluating achievement of optimal outcomes in nephron-
sparing surgery. Eur Urol 62:617–618. doi:10.1016/j.eururo.2012.06.001 
CrossRefPubMedGoogle Scholar 
4. 4. 
Khalifeh A et al (2013) Comparative outcomes and assessment of trifecta in 500 robotic and 
laparoscopic partial nephrectomy cases: a single surgeon experience. J Urol 189:1236–1242. 
doi:10.1016/j.juro.2012.10.021 CrossRefPubMedGoogle Scholar 
5. 5. 
Zargar H et al (2014) Trifecta and optimal peri-operative outcomes of robotic and 
laparoscopic partial nephrectomy in surgical treatment of small renal masses: a multi-
institutional study. BJU Int. doi:10.1111/bju.12933 Google Scholar 
6. 6. 
Zargar H et al (2014) Minimally invasive partial nephrectomy in the age of the ‘trifecta’. 
BJU Int. doi:10.1111/bju.12698 Google Scholar 
7. 7. 
Zargar H et al (2015) Ipsilateral renal function preservation after robot-assisted partial 
nephrectomy (RAPN): an objective analysis using mercapto-acetyltriglycine (MAG3) renal 
scan data and volumetric assessment. BJU Int 115:787–795. doi:10.1111/bju.12825 
CrossRefPubMedGoogle Scholar 
8. 8. 
Porpiglia F et al (2014) Evaluation of functional outcomes after laparoscopic partial 
nephrectomy using renal scintigraphy: clamped vs clampless technique. BJU Int. 
doi:10.1111/bju.12834 Google Scholar 
9. 9. 
Kaouk JH et al (2012) Robot-assisted laparoscopic partial nephrectomy: step-by-step 
contemporary technique and surgical outcomes at a single high-volume institution. Eur Urol 
62:553–561. doi:10.1016/j.eururo.2012.05.021 CrossRefPubMedGoogle Scholar 
10. 10. 
Porpiglia F, Volpe A, Billia M, Renard J, Scarpa RM (2008) Assessment of risk factors for 
complications of laparoscopic partial nephrectomy. Eur Urol 53:590–596. 
doi:10.1016/j.eururo.2007.10.036 CrossRefPubMedGoogle Scholar 
11. 11. 
Hu JC et al (2014) Technique and outcomes of robot-assisted retroperitoneoscopic partial 
nephrectomy: a multicenter study. Eur Urol 66:542–549. doi:10.1016/j.eururo.2014.04.028 
CrossRefPubMedGoogle Scholar 
12. 12. 
Rizkala ER et al (2013) Zero ischemia robotic partial nephrectomy: sequential preplaced 
suture renorrhaphy technique. Urology 82:100–104. doi:10.1016/j.urology.2013.03.042 
CrossRefPubMedGoogle Scholar 
13. 13. 
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 
40:373–383CrossRefPubMedGoogle Scholar 
14. 14. 
Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive 
standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–
853. doi:10.1016/j.juro.2009.05.035 CrossRefPubMedGoogle Scholar 
15. 15. 
Clavien PA et al (2009) The Clavien-Dindo classification of surgical complications: five-
year experience. Ann Surg 250:187–196. doi:10.1097/SLA.0b013e3181b13ca2 
CrossRefPubMedGoogle Scholar 
16. 16. 
Levey AS et al (2006) Using standardized serum creatinine values in the modification of 
diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 
145:247–254CrossRefPubMedGoogle Scholar 
17. 17. 
Nice. Chronic kidney disease: full guideline. http://guidance.nice.org.uk/cg73  
18. 18. 
Khalifeh A et al (2013) Positive surgical margins in robot-assisted partial nephrectomy: a 
multi-institutional analysis of oncologic outcomes (leave no tumor behind). J Urol 
190:1674–1679. doi:10.1016/j.juro.2013.05.110 CrossRefPubMedGoogle Scholar 
19. 19. 
Volpe A et al (2015) Renal ischemia and function after partial nephrectomy: a collaborative 
review of the literature. Eur Urol. doi:10.1016/j.eururo.2015.01.025 Google Scholar 
20. 20. 
Mir MC et al (2013) Parenchymal volume preservation and ischemia during partial 
nephrectomy: functional and volumetric analysis. Urology 82:263–268. 
doi:10.1016/j.urology.2013.03.068 CrossRefPubMedGoogle Scholar 
21. 21. 
Leslie S et al (2014) Renal tumor contact surface area: a novel parameter for predicting 
complexity and outcomes of partial nephrectomy. Eur Urol 66:884–893. 
doi:10.1016/j.eururo.2014.03.010 CrossRefPubMedGoogle Scholar 
 
